Past meetings
Next-Generation Trials for HER2-positive Breast Cancer (BCSC CTPM Meeting) May 16-17, 2011
Brain Metastases in Breast Cancer Workshop March 1-2, 2009
Correlative Science Committee Biomarker Workshop February 23-24, 2009
NCI-sponsored meeting on “Preoperative Therapy in Invasive Breast Cancer” March 26-27, 2007
Active NABCG trials (Group trials as listed on the CTSU website)
Closed phase 3 Cooperative Group breast cancer trials and other NABCG clinical trials
Specimens available from NABCG Cooperative Group trials /
NABCG Correlative Sciences Committee
The NCI Cooperative Groups that make up the NABCG include:
NABCG is dedicated to the study and advancement of breast cancer therapies through inter-Group collaboration on NCI-sponsored clinical trials. Additionally, this mission includes investigation into biologic correlates and quality of life in breast cancer through performance of correlative and companion studies associated with these trials.
Thomas Buchholz, M.D., F.A.C.R.
Division Head, Division of Radiation Oncology, University of Texas MD Anderson Cancer Center
Co-Chair, Breast Cancer Steering Committee (BCSC)
Email: tbuchhol@mdanderson.org
Nancy Davidson, M.D.
Director of the University of Pittsburgh Cancer Institute (UPCI)
Co-Chair, Breast Cancer Steering Committee (BCSC)
Email: davidsonne@upmc.edu
Charles Geyer, Jr., M.D., F.A.C.P.
Chair Emeritus, Breast Cancer Steering Committee (BCSC)
Email: charles.geyer@ctnet.org
Jo Anne Zujewski, M.D.
Head of Breast Cancer Therapeutics
Clinical Investigations Branch, Cancer Therapy Evaluation Program (CTEP)
Division of Cancer Treatment and Diagnosis
National Cancer Institute
Email: zujewskj@mail.nih.gov
Jennifer Hayes, Ph.D.
Program Director
Coordinating Center for Clinical Trials (CCCT)
Office of the Director
National Cancer Institute
Email: jennifer.hayes@nih.gov
Questions about specimens/NABCG Correlative Sciences Committee:
Daniel Hayes, M.D.
Chair, NABCG Correlative Sciences Committee
Phone: 734-615-6725
Email: HayesDF@umich.edu